Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.50 -0.07 (-0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Return on Equity [ROE] (2011 - 2026)

Updated

Sarepta Therapeutics (SRPT) recorded Return on Equity [ROE] of -9.02% in Q2 2026, down 4.55 percentage points from -4.46% a year earlier and down 13.94 percentage points from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Sarepta Therapeutics reported Return on Equity [ROE] of -53.47%, down 73.18 percentage points from FY2024.

  • Annual Return on Equity [ROE] has a five-year change of +16.67 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at 19.71% in FY2024 (+105.86 pp), -86.15% in FY2023 (+21.01 pp), -107.16% in FY2022 (-57.59 pp) and -49.57% in FY2021 (+20.58 pp).
  • Quarterly Return on Equity [ROE] has ranged from -203.19% in Q1 2023 to 17.12% in Q4 2024 over the past five years.
  • On a year-over-year basis, Return on Equity [ROE] rose in three of the last eight quarters, with an average year-over-year change of +8.66 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 205.04 percentage points in Q1 2024, against a drop of 163.24 percentage points in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at 4.92% (Q1 2026), -57.98% (Q4 2025) and -19.93% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Sarepta Therapeutics 1.85 Bn -1.38 Bn 251.87 Mn -9.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.02%
Mar 31, 2026 4.92%
Dec 31, 2025 -57.98%
Sep 30, 2025 -19.93%
Jun 30, 2025 -4.46%
Mar 31, 2025 -18.28%
Dec 31, 2024 17.12%
Sep 30, 2024 10.61%
Jun 30, 2024 4.64%
Mar 31, 2024 1.85%
Dec 31, 2023 -66.03%
Sep 30, 2023 -91.77%
Jun 30, 2023 -124.84%
Mar 31, 2023 -203.19%
Dec 31, 2022 -172.47%
Sep 30, 2022 -123.78%
Jun 30, 2022 -64.00%
Mar 31, 2022 -39.95%
Dec 31, 2021 -59.93%
Sep 30, 2021 -101.84%
API Access

Sarepta Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SRPT&period=max&api_key=YOUR_API_KEY